Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Testicular Neoplasms 4Testicular Germ Cell Tumor 3Sarcoma 3Central Nervous System Neoplasms 3Teratoma 2Rhabdoid Tumor 2Ovarian Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Prostatic Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroblastoma 1Nephroma, Mesoblastic 1Neoplasms, Unknown Primary 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cisplatin 11Paclitaxel 9Ifosfamide 9Filgrastim 8Etoposide 8Bleomycin 7Carboplatin 5pegfilgrastim 3Peripheral Blood Stem Cell Transplantation 3liposomal amphotericin B 2Therapeutics 2Radiotherapy 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2sargramostim 1sabarubicin 1ixabepilone 1etoposide phosphate 1aldesleukin 1Vincristine 1Vinblastine 1Thiotepa 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Ribavirin 1Psychiatric Rehabilitation 1Palivizumab 1Oxaliplatin 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endodermal Sinus Tumor × etoposide phosphate × Genitourinary × Clear all
NCT00301782 2013-08-26

Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors

National Cancer Institute (NCI)

Phase 2 Completed
88 enrolled
Genitourinary

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡